JIC Venture Growth Investments

JIC Venture Growth Investments is the venture growth arm tied to Japan Investment Corporation, the government-backed institution structured to address late-stage funding gaps for Japanese deep tech and life sciences. Operating from Tokyo, the firm explicitly targets companies that need capital to bridge from technical proof to scaled commercial reality, with healthcare exposure spanning biotech, deep tech, and life sciences tools. Its government-backed positioning gives it a long capital horizon and a mandate to build national champions rather than chase short-cycle returns. Limited public information is available about individual partner attribution for specific deals, but the firm’s institutional positioning is widely understood.

Check sizes run from approximately five to twenty-five million dollars, concentrated at Series B, Series C, and growth stages. Geographic focus is Japan, with strong appetite for Japanese companies expanding internationally and willingness to support cross-border syndicates that bring strategic capital alongside JIC’s commitment. The fund is sized to play a meaningful role in the kind of late-stage rounds that Japanese deep tech and biotech companies have historically struggled to assemble domestically.

For founders, JIC Venture Growth Investments is a natural conversation when a Japanese deep tech or life sciences company is past Series A, has technical and clinical validation, and needs the kind of capital that has historically required leaving Japan. Expect a partner with patience and regulatory sophistication, comfortable with long timelines and complex syndicates. Companies looking for hands-on operating help in early product-market fit work are likely a less natural match. The fit is strongest for founders ready to scale capital-intensive, technically deep businesses with national strategic relevance.